Results 201 to 210 of about 2,437,403 (392)

Tranexamic Acid for Hyperpigmentation Disorders: A Literature Review on Efficacy and Safety in Melasma and PIH

Journal of Cosmetic Dermatology, Volume 25, Issue 2, February 2026.
ABSTRACT Background Hyperpigmentation disorders, including melasma and post‐inflammatory hyperpigmentation (PIH), are common dermatologic conditions associated with significant cosmetic and psychological burden. Tranexamic acid (TXA), an antifibrinolytic agent, has gained increasing attention due to its anti‐inflammatory and antimelanogenic properties.
Ahmed AlJabr, Aseel Muhana I. AlAnazi, Rakan Abdulkarim A. AlEtebi   +2 more
wiley   +1 more source

In vivo optoacoustic imaging of endothelin receptor expression and treatment response in the hypoxic tumor microenvironment. [PDF]

Eur J Nucl Med Mol Imaging
Höltke C, Mallik M, Stölting M, Hoffmann E, Geyer C, Erapaneedi R, Kiefer F, Helfen A.   +7 more
europepmc   +1 more source

Clinicians' preferences for managing aneurysmal subarachnoid hemorrhage using endothelin receptor antagonists. [PDF]

Front Neurol, 2023
Heidenreich S, Trapali M, Krucien N, Phillips-Beyer A.   +3 more
europepmc   +1 more source

Pathogenic Gαo Mutants Drive Dominant GPCR Coupling in GNAO1 Encephalopathies

The FASEB Journal, Volume 40, Issue 1, 15 January 2026.
Mutations in GNAO1, the gene encoding Gαo, are associated with a wide range of neurodevelopmental disorders. In this study, we show that Gαo variants linked to the most severe patient phenotypes fail to disengage from activated Gi/o‐coupled GPCRs, thereby blocking GRK‐mediated receptor phosphorylation and internalization.
Yonika A. Larasati, Camille Rabesahala de Meritens, Miriam Stoeber, Vladimir L. Katanaev, Gonzalo P. Solis   +4 more
wiley   +1 more source

The role of endothelin receptor antagonists in kidney disease. [PDF]

Ren Fail
Ma X, Liang Y, Chen W, Zheng L, Lin H, Zhou T.   +5 more
europepmc   +1 more source

ENDOTHELIN TYPE B RECEPTOR COULD BE ASSOCIATED WITH A PRO-CATABOLIC AND PRO-HYPERTROPHIC PHENOTYPE IN CHONDROCYTES [PDF]

EL MAKHLOUFI Jaouhara, Man Ting Au, Lanlan Zhang, B. Samia, CAMBON Adeline, WANHERDRICK Kristell, Francis Bérenbaum, Chunyi Wen, HOUARD Xavier   +8 more
openalex   +1 more source

Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation [PDF]

, 1999
I. Herrero
openalex   +1 more source

Downregulation of Microvascular Endothelial Type B Endothelin Receptor Is a Central Vascular Mechanism in Hypertensive Pregnancy

HYPERTENSION, 2014
M. Mazzuca, Wei Li, O. Reslan, Peng Yu, Karina M. Mata, R. Khalil   +5 more
semanticscholar   +1 more source

Current Challenges in Hemostasis and Advances in Particle‐Assisted Styptic Devices

Advanced Healthcare Materials, Volume 15, Issue 2, 14 January 2026.
Here persistent limitations in hemostatic technologies are highlighted and cutting‐edge biomimetic, microparticle‐assisted, and nanoengineered systems with integrated drug delivery are showcased. Moreover, the article identifies fresh directions toward the next‐generation of multifunctional hemostatic devices with superior efficacy and accessibility ...
Daniele Baiocco, Zhibing Zhang, Neil M. Eisenstein, Nigel Tai, Liam M. Grover   +4 more
wiley   +1 more source

Endothelin Receptor Antagonists for the Treatment of Hypertension: Recent Data from Clinical Trials and Implementation Approach. [PDF]

Curr Cardiol Rep
Manickavasagar R, Krishnan A, Azzam O, Schlaich MP.   +3 more
europepmc   +1 more source